COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 1952: Articles 19511-19520  | Next

Emerging SARS-CoV-2 diversity revealed by rapid whole genome sequence typing.
Moustafa, A. M., Planet, P.
10.1101/2020.12.28.424582 — Posted: 2020-12-28
MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans
Castro, A., Ozturk, K., Zanetti, M., Carter, H.
10.1101/2020.12.26.424449 — Posted: 2020-12-28
Can age-distribution be an indicator of the goodness of COVID-19 testing?
Hoseinpour Dehkordi, A., Nemati, R., Tavousi, P.
10.1101/2020.12.21.20248690 — Posted: 2020-12-28
Maori and Pacific People in New Zealand have higher risk of hospitalisation for COVID-19
Steyn, N., Binny, R. N., Hannah, K., Hendy, S., James, A., Lustig, A., Ridings, K., Plank, M. J., Sporle, A.
10.1101/2020.12.25.20248427 — Posted: 2020-12-28 Discussion: Onsite
The neutralization effect of Montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
Durdagi, S., Avsar, T., Orhan, M. D., Serhatli, M., Balcioglu, B. K., Ozturk, H. U., Kayabolen, A., Cetin, Y., Aydinlik, S., Bagci-Onder, T., Tekin, S., Demirci, H., Guzel, M., Akdemir, A., Calis, S., Oktay, L., Tolu, I., Butun, Y. E., Erdemoglu, E., Olkan, A., Tokay, N., Isik, S., Ozcan, A., Acar, E., Buyukkilic, S., Yumak, Y.
10.1101/2020.12.26.424423 — Posted: 2020-12-27
The mechanism of SARS-CoV-2 nucleocapsid protein recognition by the human 14-3-3 proteins
Tugaeva, K. V., Hawkins, D. E. D. P., Smith, J. L. R., Bayfield, O. W., Ker, D.-S., Sysoev, A. A., Klychnikov, O. I., Antson, A. A., Sluchanko, N. N.
10.1101/2020.12.26.424450 — Posted: 2020-12-27
SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans
Konishi, T.
10.1101/2020.12.23.424267 — Posted: 2020-12-27
Disruption of nasal bacteria enhances protective immune responses to influenza A virus and SARS-CoV-2 infection in mice
Nagai, M., Moriyama, M., Ichinohe, T.
10.1101/2020.12.25.424300 — Posted: 2020-12-27
Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study
Basso, D., Aita, A., Padoan, A., Cosma, C., Navaglia, F., Moz, S., Contran, N., Zambon, C.-F., Cattelan, A. M., Plebani, M.
10.1101/2020.12.24.20248825 — Posted: 2020-12-27
S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-PCR
Kidd, M., Richter, A., Best, A., Mirza, J., Percival, B., Mayhew, M., Megram, O., Ashford, F., White, T., Moles-Garcia, E., Crawford, L., Bosworth, A., Plant, T., McNally, A.
10.1101/2020.12.24.20248834 — Posted: 2020-12-27 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).